Design Therapeutics DSGN
NASDAQ DSGN
$10.48 -0.25 (-2.33%)
As of: Oct 22, 2026 · 1:25 PM EDT

Design Therapeutics (DSGN) Revenue (2020)

Updated

Design Therapeutics' Revenue was $33,000 in Q4 2020, up 65.0% from the prior quarter.

Analysis

Design Therapeutics (DSGN) Revenue (2020) Analysis & Trends

For FY2020, Revenue at Design Therapeutics came in at $226,000.

  • Quarterly Revenue has moved between $20,000 (Q3 2020) and $142,000 (Q1 2020) over five years.
  • Per Business Quant data, DSGN's Revenue in the three quarters before Q4 2020 was $20,000 (Q3 2020), $31,000 (Q2 2020) and $142,000 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,167.42 Bn 1,136.01 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 644.33 Bn 564.19 Bn 17.30 Bn 25.40 Bn
3 AbbVie 501.62 Bn 474.73 Bn 12.70 Bn 16.99 Bn
4 Merck 360.58 Bn 314.96 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 302.22 Bn 266.21 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 267.65 Bn 241.33 Bn 12.86 Bn 15.38 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 192.96 Bn 167.16 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Design Therapeutics 655.06 Mn -200.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 33,000.00
Sep 30, 2020 20,000.00
Jun 30, 2020 31,000.00
Mar 31, 2020 142,000.00
API Access

Design Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=DSGN&period=max&api_key=YOUR_API_KEY